Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Desvenlafaxine (Pristiq) vs. Placebo in the Treatment of Chronic Depression

NCT01537068 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT01537068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Desvenlafaxine (Pristiq) vs. Placebo in the Treatment of Chronic Depression
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2016
Enrollment
59 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic depressive disorder, dysthymia, dysthymic disorder